Continuous vs Intermittent Meropenem Administration in Criti

This randomized clinical trial compares the effect of continuous administration of meropenem vs intermittent administration on a composite outcome of mortality

Related Keywords

Croatia , Russia , Milan , Lombardia , Italy , Northern Ireland , Craigavon , United Kingdom , Santarpino , Campania , Belfast , Kazakhstan , Italian , Giovanni Landoni , Baiardo Redaelli , Christopher Seymour , Aurobindo Pharma , Edwards Lifesciences , Italian Medicines Agency , San Raffaele Scientific Institute , Group Information , Study Drug Administration , Intermittent Administration Of Meropenem , Sepsis Campaign , Gilead Sciences , Pfizer , Department Of Anesthesia , Umehara Memorial Foundation , Pearson , Orion Pharma Ltd , Surviving Sepsis Campaign , Continuous Infusion , Intermittent Administration , Critically Ill Patients , Sequential Organ Failure Assessment , Simplified Acute Physiology Score , Study Management , Coma Scale , Secondary Outcomes , Drug Administration , Antibiotic Treatment , Identified Bacteria , Primary Outcome , Associate Editor , Intensive Care , Raffaele Scientific Institute , Via Olgettina , Interest Disclosures , Umehara Memorial , Thermo Fisher , Critical Care Reviews Meeting ,